Workplace accidents cost $136 billion annually. Among the major causes of impairment are drugs, alcohol, or fatigue. The legalization of recreational Marijuana has had an impact. Accident and injury rates with Marijuana testing positive increased sharply. Because Marijuana and other drugs remain in the body long after use, urine, and saliva tests typically only reveal the presence of the drug, but do not detect whether a person is impaired at the time of the test. That is why impairment screening is necessary. ZXEREX has developed the world’s first science-based impairment detection enhanced with AI and machine learning in studies conducted at major research institutions to deliver rapid, accurate, low-cost, non-invasive Impairment screening.

ZXEREX-Safe™ and Impair-ID™ identify the effects of drugs on the brain and detect temporary neurologic impairment. ZXEREX deals with current Impairment by screening for temporary changes in the brain a person is impaired.  Screening is not a replacement for infrequent and costly random drug testing that can confirm the presence of a substance and even remain positive long after the person is no longer impaired. 

ZXEREX screening is non-invasive, cost-effective, and fast (2-3 minutes) and can be scheduled to maximize risk mitigation. 

ZXEREX screening when combined with a company’s safety program, helps to deter risky behavior such as showing up to work impaired or using while on the job.